Skip to content
TrialScanner

NCT04996875

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Phase 2RecruitingCOGTLead

Registry record

Lead sponsor
Cogent Biosciences, Inc.
Conditions
Advanced Systemic Mastocytosis (AdvSM); SM With an Associated Hematologic Neoplasm (SM-AHN); Mast Cell Leukemia (MCL); Aggressive Systemic Mastocytosis (ASM)
Primary completion
Sep 19, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04996875 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04996875: (Apex) Bezuclastinib in... | TrialScanner